logoCabeceraNinos

Hemos leído sobre ... Lupus

Última actualización: 10 marzo 2017


FEBRERO 2017
  • Beukelman T, Curtis JR, Saag KG.
    Serious Infections in Childhood-Onset Systemic Lupus Erythematosus: Using Administrative Claims Data to Investigate Disease Outcomes.
    Arthritis Care Res (Hoboken). 2017 Feb 19. doi: 10.1002/acr.23221. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28217857
  • Basu B, Roy B, Babu BG.
    Efficacy and safety of rituximab in comparison with common induction therapies in pediatric active lupus nephritis.
    Pediatr Nephrol. 2017 Feb 12. doi: 10.1007/s00467-017-3583-x. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28191596
  • Tian SY, Silverman ED, Pullenayegum E, Brown PE, Beyene J, Feldman BM.
    Comparative effectiveness of mycophenolate mofetil for the treatment of childhood-onset proliferative lupus nephritis.
    Arthritis Care Res (Hoboken). 2017 Feb 9. doi: 10.1002/acr.23215. [Epub ahead of print]
      https://www.ncbi.nlm.nih.gov/pubmed/28182833
  • Sönmez HE, Karhan AN, Batu ED, Bilginer Y, Gümüş E, Demir H, Yüce A, Özen S.
    Gastrointestinal system manifestations in juvenile systemic lupus erythematosus.
    Clin Rheumatol. 2017 Feb 16. doi: 10.1007/s10067-017-3571-3. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28204893
  • Raeeskarami SR, Shahbaznejad L, Assari R, Aghighi Y.
    Pseudotumor Cerebri as the First Manifestation of Juvenile Systemic Lupus Erythematosus.
    Iran J Pediatr. 2016 Jul 12;26(5):e5176. doi: 10.5812/ijp.5176. eCollection 2016.
    https://www.ncbi.nlm.nih.gov/pubmed/28203329
  • Kotait MA, Abd Elnabi HH, Gabr TA.
    Juvenile systemic lupus erythematosus (jSLE): Auditory pathway affection in relation to disease activity.
    Int J Pediatr Otorhinolaryngol. 2017 Feb;93:150-156. doi: 10.1016/j.ijporl.2016.12.007. Epub 2016 Dec 18.
    https://www.ncbi.nlm.nih.gov/pubmed/28109488
  • Harris JG, Maletta KI, Kuhn EM, Olson JC.
    Evaluation of quality indicators and disease damage in childhood-onset systemic lupus erythematosus patients.
    Clin Rheumatol. 2017 Feb;36(2):351-359. doi: 10.1007/s10067-016-3518-0. Epub 2016 Dec 24.
    https://www.ncbi.nlm.nih.gov/pubmed/28013435
  • Fatemi A, Matinfar M, Smiley A.
    Childhood versus adult-onset systemic lupus erythematosus: long-term outcome and predictors of mortality.
    Clin Rheumatol. 2017 Feb;36(2):343-350. doi: 10.1007/s10067-016-3509-1. Epub 2016 Dec 23.
    https://www.ncbi.nlm.nih.gov/pubmed/28012055
  • Novak GV, Marques M, Balbi V, Gormezano NW, Kozu K, Sakamoto AP, Pereira RM, Terreri MT, Magalhães CS, Guariento A, Sallum AM, Marini R, Ferriani VP, Barbosa CM, de Castro TC, Ramos VC, Bonfá E, Silva CA.
    Anti-RO/SSA and anti-La/SSB antibodies: Association with mild lupus manifestations in 645 childhood-onset systemic lupus erythematosus.
    Autoimmun Rev. 2017 Feb;16(2):132-135. doi: 10.1016/j.autrev.2016.12.004. Epub 2016 Dec 14.
    https://www.ncbi.nlm.nih.gov/pubmed/27988434

ENERO 2017
  • Lim LS, Pullenayegum E, Lim L, Gladman D, Feldman B, Silverman E.
    From Childhood to Adulthood: The Trajectory of Damage in Patients with Childhood-Onset Systemic Lupus Erythematosus.
    Arthritis Care Res (Hoboken). 2017 Jan 24. doi: 10.1002/acr.23199. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28118527
  • Nanthapisal S, Omoyinmi E, Murphy C, Standing A, Eisenhut M, Eleftheriou D, Brogan PA.
    Early-Onset Juvenile SLE Associated With a Novel Mutation in Protein Kinase C δ.
    Pediatrics. 2017 Jan;139(1). pii: e20160781. doi: 10.1542/peds.2016-0781. Epub 2016 Dec 21.
    https://www.ncbi.nlm.nih.gov/pubmed/28003329
  • Fonseca R, Aguiar F, Rodrigues M, Brito I.
    Clinical phenotype and outcome in lupus according to age: a comparison between juvenile and adult onset.
    Reumatol Clin. 2016 Dec 28. pii: S1699-258X(16)30156-5. doi: 10.1016/j.reuma.2016.10.011. [Epub ahead of print] English, Spanish.
    https://www.ncbi.nlm.nih.gov/pubmed/28012055
DICIEMBRE 2016
  • AlE'ed A, Vega-Fernandez P, Muscal E, Hinze C, Tucker LB, Appenzeller S, Bader-Meunier B, Roth J, Torrente-Segarra V, Klein-Gitelman MS, Levy DM, Roebuck-Spencer T, Brunner H; CARRA NPSLE Working Group.
    The Challenges of Diagnosing Cognitive Dysfunction with Neuropsychiatric Systemic Lupus Erythematosus in Childhood.
    Arthritis Care Res (Hoboken). 2016 Dec 19.
    https://www.ncbi.nlm.nih.gov/pubmed/27992660
  • Harris JG, Maletta KI, Kuhn EM, Olson JC.
    Evaluation of quality indicators and disease damage in childhood-onset systemic lupus erythematosus patients.
    Clin Rheumatol. 2016 Dec 24.
    https://www.ncbi.nlm.nih.gov/pubmed/28013435
  • Fatemi A, Matinfar M, Smiley A.
    Childhood versus adult-onset systemic lupus erythematosus: long-term outcome and predictors of mortality.
    Clin Rheumatol. 2016 Dec 23.
    https://www.ncbi.nlm.nih.gov/pubmed/28012055
  • Ambrose N, Morgan TA, Galloway J, Ionnoau Y, Beresford MW, Isenberg DA; UK JSLE Study Group.
    Differences in disease phenotype and severity in SLE across age groups.
    Lupus. 2016 Dec;25(14):1542-1550.
    https://www.ncbi.nlm.nih.gov/pubmed/27147622
  • Sakamoto AP, Silva CA, Ferriani MP, Pereira RM, Bonfá E, Saad-Magalhães C, Okuda E, Appenzeller S, Gomes FH, Cunha AL, Salume MH, Piotto DP, Terreri MT.
    Characterization of chronic arthritis in a multicenter study of 852 childhood-onset systemic lupus erythematosus patients.
    Rheumatol Int. 2016 Dec;36(12):1641-1648.
    https://www.ncbi.nlm.nih.gov/pubmed/27629113

NOVIEMBRE 2016
  • van Vollenhoven R, Voskuyl A, Bertsias G, Aranow C, Aringer M, Arnaud L, Askanase A, Balážová P, Bonfa E, Bootsma H, Boumpas D, Bruce I, Cervera R, Clarke A, Coney C, Costedoat-Chalumeau N, Czirják L, Derksen R, Doria A, Dörner T, Fischer-Betz R, Fritsch-Stork R, Gordon C, Graninger W, Györi N, Houssiau F, Isenberg D, Jacobsen S, Jayne D, Kuhn A, Le Guern V, Lerstrøm K, Levy R, Machado-Ribeiro F, Mariette X, Missaykeh J, Morand E, Mosca M, Inanc M, Navarra S, Neumann I, Olesinska M, Petri M, Rahman A, Rekvig OP, Rovensky J, Shoenfeld Y, Smolen J, Tincani A, Urowitz M, van Leeuw B, Vasconcelos C, Voss A, Werth VP, Zakharova H, Zoma A, Schneider M, Ward M.
    A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS).
    Ann Rheum Dis. 2016 Nov 24.
    https://www.ncbi.nlm.nih.gov/pubmed/27884822
  • Gomes RC, Silva MF, Kozu K, Bonfá E, Pereira RM, Terreri MT, Magalhães CS, Sacchetti SB, Marini R, Fraga M, Carvalho LM, Barbosa CM, Carneiro-Sampaio M, Silva CA.
    Features of 847 Childhood-Onset Systemic Lupus Erythematosus Patients in Three Age Groups at Diagnosis: A Brazilian Multicenter Study.
    Arthritis Care Res (Hoboken). 2016 Nov;68(11):1736-1741
    https://www.ncbi.nlm.nih.gov/pubmed/27014968
  • Pisetsky DS, Rovin BH, Lipsky PE.
    Biomarkers as Entry Criteria for Clinical Trials of New Therapies for Systemic Lupus Erythematosus: The Example of ANA and anti-DNA.
    Arthritis Rheumatol. 2016 Nov 29
    https://www.ncbi.nlm.nih.gov/pubmed/27899010
  • Massarotti EM, Allore HG, Costenbader K.
    Interferon-Targeted Therapy for SLE: Are the Trials on Target?
    Arthritis Rheumatol. 2016 Nov 11
    https://www.ncbi.nlm.nih.gov/pubmed/27860434
  • Gao R, Yu W, Wen Y, Li H.
    Beta2-glycoprotein-I Expression in Lupus Nephritis Patients with Antiphospholipid-associated Nephropathy.
    J Rheumatol. 2016 Nov;43(11):2026-2032.
    https://www.ncbi.nlm.nih.gov/pubmed/27633824

SEPTIEMBRE 2016
  • Smith EM, Jorgensen AL, Midgley A, Oni L, Goilav B, Putterman C, Wahezi D, Rubinstein T, Ekdawy D, Corkhill R, Jones CA, Marks SD, Newland P, Pilkington C, Tullus K, Beresford MW.
    International validation of a urinary biomarker panel for identification of active lupus nephritis in children.
    Pediatr Nephrol. 2016 Sep 3.
    https://www.ncbi.nlm.nih.gov/pubmed/27590021
  • Al-Obaidi M, Saunders D, Brown S, Ramsden L, Martin N, Moraitis E, Pilkington CA, Brogan PA, Eleftheriou D.
    Evaluation of magnetic resonance imaging abnormalities in juvenile onset neuropsychiatric systemic lupus erythematosus.
    Clin Rheumatol. 2016 Oct;35(10):2449-56.
    https://www.ncbi.nlm.nih.gov/pubmed/27527090
  • Fotis L, Baszis KW, White AJ, French AR.
    Four Cases of Anti-PM/Scl Antibody-positive Juvenile Overlap Syndrome with Features of Myositis and Systemic Sclerosis.
    J Rheumatol. 2016 Sep;43(9):1768-9.
    https://www.ncbi.nlm.nih.gov/pubmed/27587018

AGOSTO 2016
  • Sakamoto AP, Silva CA, Ferriani MP, Pereira RM, Bonfá E, Saad-Magalhães C, Okuda E, Appenzeller S, Gomes FH, Cunha AL, Salume MH, Piotto DP, Terreri MT.
    Characterization of chronic arthritis in a multicenter study of 852 childhood-onset systemic lupus erythematosus patients.
    Rheumatol Int. 2016 Sep 14. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27629113
  • Clowse ME, Wallace DJ, Furie RA, Petri MA, Pike MC, Leszczyński P, Neuwelt CM, Hobbs K, Keiserman M, Duca L, Kalunian KC, Galateanu C, Bongardt S, Stach C, Beaudot C, Kilgallen B, Gordon C; EMBODY Investigator Group.
    Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results from the Phase 3, Randomized, Double-blind, Placebo-controlled Trials, EMBODY™ 1 and EMBODY™ 2.
    Arthritis Rheumatol. 2016 Sep 6. doi: 10.1002/art.39856. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27598855
  • Iudici M, Fasano S, Gabriele Falcone L, Pantano I, La Montagna G, Migliaresi S, Valentini G.
    Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: a long-term retrospective cohort study.
    Rheumatology (Oxford). 2016 Sep;55(9):1623-30
    http://www.ncbi.nlm.nih.gov/pubmed/27247433
  • Singh JA, Hossain A, Kotb A, Oliveira A, Mudano AS, Grossman J, Winthrop K, Wells GA.
    Treatments for Lupus Nephritis: A Systematic Review and Network Metaanalysis.
    J Rheumatol. 2016 Sep 1. pii: jrheum.160041. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27585688
  • König N, Fiehn C, Wolf C, Schuster M, Cura Costa E, Tüngler V, Alvarez HA, Chara O, Engel K, Goldbach-Mansky R, Günther C, Lee-Kirsch MA.
    Familial chilblain lupus due to a gain-of-function mutation in STING.
    Ann Rheum Dis. 2016 Aug 26. pii: annrheumdis-2016-209841. doi: 10.1136/annrheumdis-2016-209841. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27566796

JULIO 2016
  • Brunner HI, Bennett MR, Abulaban K, Klein-Gitelman MS, O'Neil KM, Tucker L, Ardoin SP, Rouster-Stevens KA, Onel KB, Singer NG, Anne Eberhard B, Jung LK, Imundo L, Wright TB, Witte D, Rovin BH5 Ying J, Devarajan P.
    Development of a Novel Renal Activity Index of Lupus Nephritis in Children and Young Adults.
    Arthritis Care Res (Hoboken). 2016 Jul;68(7):1003-11. doi: 10.1002/acr.22762.
    http://www.ncbi.nlm.nih.gov/pubmed/26473509

JUNIO 2016
  • Knight AM, Vickery ME, Muscal E, Davis AM, Harris JG, Soybilgic A, Onel KB, Schanberg LE, Rubinstein T, Gottlieb BS, Mandell DS, von Scheven E; CARRA Investigators.
    Identifying Targets for Improving Mental Healthcare of Adolescents with Systemic Lupus Erythematosus: Perspectives from Pediatric Rheumatology Clinicians in the United States and Canada.
    J Rheumatol. 2016 Jun;43(6):1136-45. doi: 10.3899/jrheum.151228.
  • Cimaz R.
    Paediatric rheumatic disease: Phenotype and prognosis of juvenile systemic lupus erythematosus.
    Nat Rev Rheumatol. 2016 Jul;12(7):382-3. doi: 10.1038/nrrheum.2016.101. Epub 2016 Jun 16.
  • Tunnicliffe DJ, Singh-Grewal D, Chaitow J, Mackie F, Manolios N, Lin MW, O'neill SG, Ralph AF, Craig JC, Tong A.
    Lupus Means Sacrifices: Perspectives of Adolescents and Young Adults With Systemic Lupus Erythematosus.
    Arthritis Care Res (Hoboken). 2016 Jun;68(6):828-37. doi: 10.1002/acr.22749
    http://www.ncbi.nlm.nih.gov/pubmed/26414860
  • Thorbinson C, Oni L, Smith E, Midgley A, Beresford MW.
    Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus.
    Paediatr Drugs. 2016 Jun;18(3):181-95. doi: 10.1007/s40272-016-0170-8.
    http://www.ncbi.nlm.nih.gov/pubmed/26971103

MAYO 2016
  •  Abujam B, Gupta A, Suri D, Rawat A, Singh S.
    Trends and predictors of mortality in childhood onset lupus in a single North-Indian centre over 23 years: a retrospective study.
    Clin Exp Rheumatol. 2016 Apr 15. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27086699
  • Joo YB, Park SY, Won S, Bae SC.
    Differences in Clinical Features and Mortality between Childhood-onset and Adult-onset Systemic Lupus Erythematosus: A Prospective Single-center Study.
    J Rheumatol published online before print June 1, 2016. doi: 10.3899/jrheum.151129.
    http://www.jrheum.org/content/early/2016/05/26/jrheum.151129.abstract
  • Knight AM, Vickery ME, Muscal E, Davis AM, Harris JG, Soybilgic A, et al.  
    Identifying Targets for Improving Mental Healthcare of Adolescents with Systemic Lupus Erythematosus: Perspectives from Pediatric Rheumatology Clinicians in the United States and Canada.
    J Rheumatol June 2016 43(6):1136-1145; published online before print April 1, 2016. doi: 10.3899/jrheum.151228
    http://www.jrheum.org/content/43/6/1136.abstract
  • Pereira KM, Faria AG, Liphaus BL, Jesus AA, Silva CA, Carneiro-Sampaio M, et al.
    Low C4, C4A and C4B gene copy numbers are stronger risk factors for juvenile-onset than for adult-onset systemic lupus erythematosus.Rheumatology (2016) 55 (5):869-873. doi: 10.1093/rheumatology/kev436
    http://rheumatology.oxfordjournals.org/content/55/5/869.abstract

ABRIL 2016
  • Banchereau R, Hong S, Cantarel B, Baldwin N, Baisch J, Edens M, Cepika AM, Acs P, Turner J, Anguiano E, Vinod P, Kahn S, Obermoser G, Blankenship D, Wakeland E, Nassi L, Gotte A, Punaro M, Liu YJ, Banchereau J, Rossello-Urgell J, Wright T, Pascual V.
    Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients.
    Cell. 2016 Apr 21;165(3):551-65. doi: 10.1016/j.cell.2016.03.008. Epub 2016 Mar 31.
    http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27040498
  • George A, Wong-Pak A, Peschken CA, Silverman E, Pineau C, Smith CD, Arbillaga H, Zummer M, Bernatsky S, Hudson M, Hitchon C, Fortin PR, Nevskaya T, Pope JE; 1000 Faces of LupusInvestigators.
    The influence of education on disease activity and damage in systemic lupus erythematous: Data from the 1000 Canadian Faces of Lupus
    Arthritis Care Res (Hoboken). 2016 Apr 25. doi: 10.1002/acr.22922. [Epub ahead of print]
    http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27110869

MARZO 2016
  • Gomes RC, Silva MF, Kozu K, Bonfá E, Pereira RM, Terreri MT, Magalhães CS, et al.
    Features of 847 Childhood-Onset Systemic Lupus Erythematousus Patients in Three Age Groups at Diagnosis: A Brazilian Multicenter Study.
    Arthritis Care Res (Hoboken). 2016 Mar 25. doi: 10.1002/acr.22881. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27014968
  • Sousa S, Gonçalves MJ, Inês LS, Eugénio G, Jesus D, Fernandes S, et al.
    Clinical features and long-term outcomes of systemic lupus erythematosus: comparative data of childhood, adult and late-onset disease in a national register.
    Rheumatol Int. 2016 Mar 15. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26979603
  • Lube GE, Ferriani MP, Campos LM, Terreri MT, Bonfá E, Magalhães CS, Aikawa NE, Piotto DP, Peracchi OA, Dos Santos MC, Appenzeller S, Ferriani VP, Pereira RM, Silva CA.
    Evans Syndrome at Childhood-Onset Systemic Lupus Erythematosus Diagnosis: A Large Multicenter Study.
    Pediatr Blood Cancer. 2016 Mar 28. doi: 10.1002/pbc.25976. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27018636
  • Khamashta M, Merrill JT, Werth VP, Furie R, Kalunian K, Illei GG, Drappa J, Wang L, Greth W; CD1067 study investigators.
    Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study.
    Ann Rheum Dis. 2016 Mar 23. pii: annrheumdis-2015-208562. doi: 10.1136/annrheumdis-2015-208562. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27009916
  • Driest KD, Sturm MS, O'Brien SH, Spencer CH, Stanek JR, Ardoin SP; CARRA Registry Investigators.
    Factors associated with thrombosis in pediatric patients with systemic lupus erythematosus.
    Lupus. 2016 Mar 14. pii: 0961203316638164. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26980741
  • AlKharafi NN, Alsaeid K, AlSumait A, Al-Sabah H, Al-Ajmi H, Rahim JA, Al-Enezi H, Nanda A.
    Cutaneous Lupus Erythematosus in Children: Experience from a Tertiary Care Pediatric Dermatology Clinic.
    Pediatr Dermatol. 2016 Mar;33(2):200-8. doi: 10.1111/pde.12788.
    http://www.ncbi.nlm.nih.gov/pubmed/27001318
  • Lapa AT, Postal M, Sinicato NA, Ferreira WG, Bellini BS, Fernandes PT, Rittner L, Marini R, Cendes F, Appenzeller S.
    Reduction of cerebral and corpus callosum volumes in childhood-onset systemic lupus erythematosus. A volumetric magnetic resonance imaging analysis.
    Arthritis Rheumatol. 2016 Mar 18. doi: 10.1002/art.39680. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26991912
  • Son MB, Sergeyenko Y, Guan H, Costenbader KH.
    Disease activity and transition outcomes in a childhood-onset systemic lupus erythematosus cohort.
    Lupus. 2016 Mar 23. pii: 0961203316640913. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27013665
  • Cho H, Kim YW, Suh CH, Jung JY, Um YJ, Jung JH, Kim HA.
    Concordance between the tuberculin skin test and interferon gamma release assay (IGRA) for diagnosing latent tuberculosis infection in patients with systemic lupus erythematosus and patient characteristics associated with an indeterminate IGRA.
    Lupus. 2016 Mar 15. pii: 0961203316639381. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26985011
  • Wei LQ, Liang YG, Zhao Y, Liang HT, Qin DC, She MC.
    Efficacy and Safety of Belimumab Plus Standard Therapy in Patients With Systemic Lupus Erythematosus: A Meta-analysis.
    Clin Ther. 2016 Mar 24. pii: S0149-2918(16)30091-1. doi: 10.1016/j.clinthera.2016.02.022. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27021607
  • Danion F, Rosine N, Belkhir R, Gottenberg JE, Hachulla E, Chatelus E, et al for the Club Rhumatismes et Inflammation section of the French Society of Rheumatology.
    Efficacy of abatacept in systemic lupus erythematosus: a retrospective analysis of 11 patients with refractory disease.
    Lupus. 2016 Mar 24. pii: 0961203316640911. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27013663
  • Mok MY, Shoenfeld Y.
    Recent advances and current state of immunotherapy in systemic lupus erythematosus.
    Expert Opin Biol Ther. 2016 Mar 31. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27032059
  • Ruiz-Larrañaga O, Migliorini P, Uribarri M, Czirják L, Alcaro MC, Del Amo J, Iriondo M, Manzano C, Escorza-Treviño S, Estonba A.
    Genetic association study of systemic lupus erythematosus and disease subphenotypes in European populations.
    Clin Rheumatol. 2016 Mar 28. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27021335
  • María Pego-Reigosa J, Lois-Iglesias A, Rúa-Figueroa Í, Galindo M, Calvo-Alén J, de Uña-Álvarez J, et al.
    Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry.
    Rheumatology (Oxford). 2016 Mar 27. pii: kew049. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27018057
  • Shimizu Y, Yasuda S, Kako Y, Nakagawa S, Kanda M, Hisada R, et al.
    Post-steroid neuropsychiatric manifestations are significantly more frequent in SLE compared with other systemic autoimmune diseases and predict better prognosis compared with de novo neuropsychiatric SLE.
    Autoimmun Rev. 2016 Mar 22. pii: S1568-9972(16)30074-X. doi: 10.1016/j.autrev.2016.03.017. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27016478
  • Galindo-Izquierdo M, Rodriguez-Almaraz E, Pego-Reigosa JM, López-Longo FJ, Calvo-Alén J, Olivé A, et al. RELESSER Group, from the Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group (EASSER).
    Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER).
    Medicine (Baltimore). 2016 Mar;95(9):e2891. doi: 10.1097/MD.0000000000002891.
    http://www.ncbi.nlm.nih.gov/pubmed/26945378
  • Fors Nieves CE, Izmirly PM.
    Mortality in Systemic Lupus Erythematosus: an Updated Review.
    Curr Rheumatol Rep. 2016 Apr;18(4):21. doi: 10.1007/s11926-016-0571-2.
    http://www.ncbi.nlm.nih.gov/pubmed/26984805
  • Wu H, Zhao M, Tan L, Lu Q.
    The key culprit in the pathogenesis of systemic lupus erythematosus: Aberrant DNA methylation
    Autoimmun Rev. 2016 Mar 10. pii: S1568-9972(16)30050-7. doi: 10.1016/j.autrev.2016.03.002. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26970492     
  • Buers I, Nitschke Y, Rutsch F.
    Novel interferonopathies associated with mutations in RIG-I like receptors.
    Cytokine Growth Factor Rev. 2016 Mar 11. pii: S1359-6101(16)30044-2. doi: 10.1016/j.cytogfr.2016.03.005. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26993858
  • Pinto AJ, Roschel H, Benatti FB, de Sá Pinto AL, Sallum AM, Silva CA, Gualano B.
    Poor agreement of objectively measured and self-reported physical activity in juvenile dermatomyositis and juvenile systemic lupus erythematosus.
    Clin Rheumatol. 2016 Mar 28. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27021334

FEBRERO 2016
  • van Weelden M, Queiroz LB, Lourenço DM, Kozu K, Lourenço B, Silva CA.
    Alcohol, smoking and illicit drug use in pediatric systemic lupus erythematosus patients.
    Rev Bras Reumatol. 2016 Feb 5. pii: S0482-5004(16)00007-3. doi: 10.1016/j.rbr.2015.10.003. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26949149
  • Carbajal-Alonso HL, García-Moreno NP, Rodríguez-Arreola B, Barrera de León JC.
    Depressive disorder in Mexican pediatric patients with systemic lupus erythematosus (SLE)
    Gac Med Mex. 2016 Jan-Feb;152(1):36-42.
    http://www.ncbi.nlm.nih.gov/pubmed/26927642
  • Guidelines for the clinical practice based on the literature and expert opinion.
    Mathian A, Arnaud L, Adoue D, Agard C, Bader-Meunier B, Baudouin V, Belizna C, Bonnotte B, Boumedine F, Chaib A, Chauchard M, Chiche L,Daugas E, Ghali A, Gobert P, Gondran G, Guettrot-Imbert G, Hachulla E, Hamidou M, Haroche J, Hervier B, Hummel A, Jourde-Chiche N, Korganow AS, Kwon T, Le Guern V, Le Quellec A, Limal N, Magy-Bertrand N, Marianetti-Guingel P, Martin T, Martin Silva N, Meyer O,Miyara M, Morell-Dubois S, Ninet J, Pennaforte JL, Polomat K, Pourrat J, Queyrel V, Raymond I, Remy P, Sacre K, Sibilia J, Viallard JF, Viau Brabant A, Hanslik T, Amoura Z; le groupe France lupus érythémateux systémique réseau (FLEUR) et les centres de référence et de compétence des lupus et syndromes des antiphospholipides.
    Prevention of infections in adults and adolescents with systemic lupus erythematosus
    Rev Med Interne. 2016 Feb 15. pii: S0248-8663(16)00032-1. doi: 10.1016/j.revmed.2016.01.005. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26899776
  • Lupus. 2016 Feb 4. pii: 0961203316629554. [Epub ahead of print]
    Subclinical pulmonary abnormalities in childhood-onset systemic lupus erythematosus patients.
    Veiga CS, Coutinho DS, Nakaie CM, Campos LM, Suzuki L, Cunha MT, Leone C, Silva CA, Rodrigues JC.
    http://www.ncbi.nlm.nih.gov/pubmed/26849883

ENERO 2016
  • Barsalou J, Bradley TJ, Tyrrell PN, Slorach C, Ng LW, Levy DM, Silverman ED.
    Impact of Disease Duration on Vascular Surrogates of Early Atherosclerosis in Childhood-Onset Systemic Lupus Erythematosus.
    Arthritis Rheumatol. 2016 Jan;68(1):237-46. doi: 10.1002/art.39423.
    http://onlinelibrary.wiley.com/doi/10.1002/art.39423/abstract
  • Lima GL, Paupitz J, Aikawa NE, Takayama L, Bonfa E, Pereira RM.
    Vitamin D Supplementation in Adolescents and Young Adults With Juvenile Systemic Lupus Erythematosus for Improvement in Disease Activity and Fatigue Scores: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Arthritis Care Res (Hoboken). 2016 Jan;68(1):91-8. doi: 10.1002/acr.22621.
    http://onlinelibrary.wiley.com/doi/10.1002/acr.22621/abstract
  • Ferreira JC, Marques HH, Ferriani MP, Gormezano NW, Terreri MT, Pereira RM, Magalhães CS, Campos LM, Bugni V, Okuda EM, Marini R, Pileggi GS, Barbosa CM, Bonfá E, Silva CA.
    Herpes zoster infection in childhood-onset systemic lupus erythematosus patients: a large multicenter study.
    Lupus. 2016 Jan 27. pii: 0961203315627203. [Epub ahead of print]
    http://lup.sagepub.com/content/early/2016/01/27/0961203315627203.abstract

DICIEMBRE 2015
  • Martínez-Barrio J, Ovalles-Bonilla JG, López-Longo FJ, González CM, Montoro M, Valor L, Martínez LP, Nieto JC, Hinojosa-Dávila MC, Bello N, Monteagudo I, Naredo E, Carreño L.
    Juvenile, adult and late-onset systemic lupus erythematosus: a long term follow-up study from a geographic and ethnically homogeneous population
    Clin Exp Rheumatol. 2015 Nov-Dec;33(6):788-94
    http://www.ncbi.nlm.nih.gov/pubmed/26575830
  • Silva MF, Ferriani MP, Terreri MT, Pereira RM, Magalhães CS, Bonfá E, Campos LM, Okuda EM, Appenzeller S, Ferriani VP, Barbosa CM, Ramos VC, Lotufo S, Silva CA.
    A Multicenter Study of Invasive Fungal Infections in Patients with Childhood-onset Systemic Lupus Erythematosus.
    J Rheumatol. 2015 Dec;42(12):2296-303. doi: 10.3899/jrheum.150142.
    http://www.ncbi.nlm.nih.gov/pubmed/26568586
  • Yang Y, Kumar S, Lim LS, Silverman ED, Levy DM.
    Risk Factors for Symptomatic Avascular Necrosis in Childhood-onset Systemic Lupus Erythematosus.

    J Rheumatol. 2015 Dec;42(12):2304-9. doi: 10.3899/jrheum.150464.
    http://www.ncbi.nlm.nih.gov/pubmed/26568601
  • Pesickova SS, Rysava R, Lenicek M, Vitek L, Potlukova E, Hruskova Z, Jancova E, Honsova E, Zavada J, Trendelenburg M, Tesar V.
    Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-up.

    Arthritis Res Ther. 2015 Dec 24;17(1):371. doi: 10.1186/s13075-015-0879-8.
    http://www.ncbi.nlm.nih.gov/pubmed/26704903

NOVIEMBRE 2015
  • Hermine I Brunner, Michael Bennett, Khalid Abulaban, Marisa Klein-Gitelman, Kathleen O'Neil, Lori Tucker, Stacy Ardoin, Kelly Rouster-Stevens, Karen Onel, Nora Singer, B. Anne Eberhard, Larry Jung, Lisa Imundo, Tracey Wright, David Witte, Brad Rovin, Jun Ying and Prasad Devarajan
    Development of a novel renal activity index of lupus nephritis in children & young adults

    Arthritis Care & Research
    DOI: 10.1002/acr.22762
    Abstract 
  • Frances Rees, Michael Doherty, Matthew Grainge, Peter Lanyon, Graham Davenport and Weiya Zhang
    The burden of co-morbidity in Systemic Lupus Erythematosus in the United Kingdom 1999-2012

    Arthritis Care & Research
    DOI: 10.1002/acr.22751
    Abstract
  • David J Tunnicliffe, Davinder Singh-Grewal, Jeffrey Chaitow, Fiona Mackie, Nicholas Manolios, Ming-Wei Lin, Sean G O'Neill, Angelique F Ralph, Jonathan C Craig and Allison Tong
    “Lupus means sacrifices” – the perspectives of adolescents and young adults with systemic lupus erythematosus
    Arthritis Care & Research
    DOI: 10.1002/acr.22749
    Abstract
  • Susanna Felsenstein, Andreas O. Reiff and Anusha Ramanathan
    Transition of Care and Health-Related Outcomes in Pediatric-Onset Systemic Lupus Erythematosus (pages 1521–1528)

    Arthritis Care & Research
    DOI: 10.1002/acr.22611
    Abstract
  • J. Martínez-Barrio, J. Ovalles-Bonilla, F. López-Longo, C. González, M. Montoro, L. Valor, L. Martínez, J. Nieto, M. Hinojosa-Dávila, N. Bello, I. Monteagudo, E. Naredo, L. Carreño
    Juvenile, adult and late-onset systemic lupus erythematosus: a long term follow-up study from a geographic and ethnically homogeneous population.

    Clinical and Experimental Rheumatology
  • Yogita Ghodke-Puranik, Timothy B. Niewold
    Immunogenetics of systemic lupus erythematosus: A comprehensive review
    Journal of Autoimmunity
    Volume 64, November 2015, Pages 125–136
  • J O Sato, J E Corrente, C Saad-Magalhães
    Chronic active disease pattern predicts early damage in juvenile systemic lupus erythematosus

    Lupus. 10.1177/0961203315599449 Lupus
    November 2015 vol. 24 no. 13 1421-1428
  • Andrea Knight, Michelle Vickery, Alexander Fiks, Frances Barg
    Barriers and facilitators for mental healthcare in pediatric lupus and mixed connective tissue disease: a qualitative study of youth and parent perspectives

    Pediatric Rheumatology 2015, 13:52 (24 November 2015)
    Abstract

OCTUBRE 2015
  • Tunnicliffe DJ, Singh-Grewal D, Chaitow J, Mackie F, Manolios N, Lin MW, O'Neill SG, Ralph AF, Craig JC, Tong A
    Lupus means sacrifices" - the perspectives of adolescents and young adults with systemic lupus erythematosus
    Arthritis Care Res (Hoboken). 2015 Sep 28. doi: 10.1002/acr.22749. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26414860
  • Hannah J, Casian A, D'Cruz D.
    Tacrolimus use in lupus nephritis: A systematic review and meta-analysis.
    Autoimmun Rev. 2015 Sep 30. pii: S1568-9972(15)00201-3. doi: 10.1016/j.autrev.2015.09.006. [Epub ahead of print] Review.
    http://www.ncbi.nlm.nih.gov/pubmed/26427983
  • Brunner HI, Bennett M, Abulaban K, Klein-Gitelman M, O'Neil K, Tucker L, Ardoin S, Rouster-Stevens K, Onel K, Singer N, Eberhard BA, Jung L, Imundo L, Wright T, Witte D, Rovin B, Ying J, Devarajan P.
    Development of a novel renal activity index of lupus nephritis in children & young adults
    Arthritis Care Res (Hoboken). 2015 Oct 16. doi: 10.1002/acr.22762. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26473509

SEPTIEMBRE 2015
  • Fernandes EC, Silva CA, Braga AL, Sallum AM, Campos LM, Farhat SC.
    Exposure to Air Pollutants and Disease Activity in Juvenile-Onset Systemic Lupus Erythematosus Patients.
    Arthritis Care Res (Hoboken). 2015 Nov;67(11):1609-14. doi: 10.1002/acr.22603.
    http://www.ncbi.nlm.nih.gov/pubmed/25892357

AGOSTO 2015
  • Sato JO, Corrente JE, Saad-Magalhães C.
    Chronic active disease pattern predicts early damage in juvenile systemic lupus erythematosus.
    Lupus. 2015 Aug 7. pii:0961203315599449. EPUB ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26253073
  • Alqanatish JT.
    Lingual Infarction in a Child With Systemic Lupus Erythematosus.
    J Clin Rheumatol. 2015 Sep;21(6):319.doi:10.1097/RHU.0000000000000284.
    http://www.ncbi.nlm.nih.gov/pubmed/26308351  
  • Borgia RE, Silverman ED.
    Childhood-onset systemic lupus erythematosus: an update.
    Curr Opin Rheumatol. 2015 Sep;27(5):483-92. doi:10.1097/BOR.0000000000000208.
    http://www.ncbi.nlm.nih.gov/pubmed/26200474

JULIO 2015
  • Mina R, Abulaban K, Klein-Gitelman M, Eberhard A, Ardoin S, Singer N, Onel K, Tucker L, O'Neil K, Wright T, Brooks E, Rouster-Stevens K, Jung L, Imundo L, Rovin B, Witte D, Ying J, Brunner HI
    Validation of the lupus nephritis clinical indices in childhood-onset systemic lupus erythematosus.
    Arthritis Care Res (Hoboken). 2015 Jul 20. doi: 10.1002/acr.22651. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26213987
  • Jones JT, Cunningham N, Kashikar-Zuck S, Brunner HI
    Pain, Fatigue and Psychological Impact on Health-related Quality of Life in Childhood-onset Lupus.
    Arthritis Care Res (Hoboken). 2015 Jul 20. doi: 10.1002/acr.22650. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26195020
  • Sule SD, Moodalbail DG, Burnham J, Fivush B, Furth SL
    Predictors of arthritis in pediatric patients with lupus.
    Pediatr Rheumatol Online J. 2015 Jul 14;13(1):30. doi: 10.1186/s12969-015-0027-7.
    http://www.ncbi.nlm.nih.gov/pubmed/26170222

JUNIO 2015
  • Kalunian KC, Merrill JT, Maciuca R, McBride JM, Townsend MJ, Wei X, Davis JC Jr, Kennedy WP.
    A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE).
    Ann Rheum Dis. 2015 Jun 2. pii: annrheumdis-2014-206090. doi: 10.1136/annrheumdis-2014-206090. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26038091
  •  Alexander T, Sarfert R, Klotsche J, Kühl AA, Rubbert-Roth A, Lorenz HM, Rech J, Hoyer BF, Cheng Q, Waka A, Taddeo A, Wiesener M, Schett G, Burmester GR, Radbruch A, Hiepe F, Voll RE.
    The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus.
    Ann Rheum Dis. 2015 Jul;74(7):1474-8. doi: 10.1136/annrheumdis-2014-206016. Epub
    http://www.ncbi.nlm.nih.gov/pubmed/25710470
  •  Haddon DJ, Diep VK, Price JV, Limb C, Utz PJ and Balboni I
    Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosus
    Arthritis Research & Therapy 2015, 17:162
    http://www.ncbi.nlm.nih.gov/pubmed/26081107
  •  Soybilgic A.
    Neuropsychiatric Systemic Lupus Erythematosus in Children.
    Pediatr Ann. 2015 Jun 1;44(6):e153-e158. doi: 10.3928/00904481-20150611-11.
    http://www.ncbi.nlm.nih.gov/pubmed/26114371
  • Mirabelli G, Cannarile F, Bruni C, Vagelli R, De Luca R, Carli L.
    One year in review 2015: systemic lupus erythematosus.
    Clin Exp Rheumatol. 2015 May-Jun;33(3):414-25.
    http://www.ncbi.nlm.nih.gov/pubmed/26106941

MAYO 2015
  • Lien Van Eyck, Lien De Somer, Diana Pombal, Simon Bornschein, Glynis Frans, Stéphanie Humblet-Baron, et al
    Brief Report: IFIH1 Mutation Causes Systemic Lupus Erythematosus With Selective IgA Deficiency (pages 1592–1597)
    Arthritis and Rheumatism.
    Article first published online: 25 MAY 2015 | DOI: 10.1002/art.39110
    http://onlinelibrary.wiley.com/doi/10.1002/art.39110/abstract
  • Hermine I. Brunner, Clovis A. Silva, Andreas Reiff, Gloria C. Higgins, Lisa Imundo, Calvin B. Williams, et al.
    Randomized, Double-Blind, Dose-Escalation Trial of Triptorelin for Ovary Protection in Childhood-Onset Systemic Lupus Erythematosus (pages 1377–1385)
    Arthritis and Rheumatism. Article first published online: 27 APR 2015 | DOI: 10.1002/art.39024
    http://onlinelibrary.wiley.com/doi/10.1002/art.39024/abstract
  • Amanda J. Steiman, Murray B. Urowitz, Dominique Ibañez, Timothy T. Li, Dafna D. Gladman, and Joan Wither
    Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus
    J Rheumatol May 2015 42(5):810-816; doi:10.3899/jrheum.140796
    http://jrheum.org/content/42/5/810.abstract
  • Leal GN, Silva KF, França CMP, Lianza AC, Andrade JL, Campos LMA et al.
    Subclinical right ventricle systolic dysfunction in childhood-onset systemic lupus erythematosus: insights from two-dimensional speckle-tracking echocardiography.
    Lupus May 2015 vol. 24 no. 6 613-620 doi: 10.1177/0961203314563135
    http://m.lup.sagepub.com/content/24/6/613
  • Helena Enocsson, Christopher Sjöwall, Lina Wirestam, Charlotte Dahle, Alf Kastbom, Johan Rönnelid, Jonas Wetterö, and Thomas Skogh
    Four Anti-dsDNA Antibody Assays in Relation to Systemic Lupus Erythematosus Disease Specificity and Activity
    J Rheumatol May 2015 42(5):817-825; published online before print February 15, 2015, doi:10.3899/jrheum.140677
    http://jrheum.org/content/42/5/817.abstract
  • Pilar Brito-Zerón, Peter M. Izmirly, Manuel Ramos-Casals, Jill P. Buyon & Munther A. Khamashta
    The clinical spectrum of autoimmune congenital heart block.
    Nature Reviews Rheumatology 11, 301–312 (2015) doi:10.1038/nrrheum.2015.29
    http://www.nature.com/nrrheum/journal/v11/n5/abs/nrrheum.2015.29.html
  • John G. Hanly
    Attribution in the assessment of nervous system disease in SLE
    Rheumatology (2015) 54 (5): 755-756 doi:10.1093/rheumatology/keu458
    http://rheumatology.oxfordjournals.org/content/54/5/755.full

ABRIL 2015
  • Wilhelmus S, Bajema IM, Bertsias GK, Boumpas DT, Gordon C, Lightstone L, Tesar V, Jayne DR.
    Lupus nephritis management guidelines compared
    Nephrol Dial Transplant. 2015 Apr 28. pii: gfv102. [Epub ahead of print] Review
    http://www.ncbi.nlm.nih.gov/pubmed/25920920
  •  Silpa-Archa S, Lee JJ, Foster CS.
    Ocular manifestations in systemic lupus erythematosus.
    Br J Ophthalmol. 2015 Apr 22. pii: bjophthalmol-2015-306629. doi: 10.1136/bjophthalmol-2015-306629. [Epub ahead of print] Review.
    http://www.ncbi.nlm.nih.gov/pubmed/25904124
    Gurion R, Tangpricha V, Yow E, Schanberg LE, McComsey GA, Robinson AB;
  • Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators.
    Avascular necrosis in pediatric systemic lupus erythematosus: a brief report and review of the literature.
    Pediatr Rheumatol Online J. 2015 Apr 23;13(1):13. doi: 10.1186/s12969-015-0008-x.
    http://www.ncbi.nlm.nih.gov/pubmed/25902709
    Acceso directo: http://www.ped-rheum.com/content/pdf/s12969-015-0008-x.pdf
  • Mohan S, Barsalou J, Bradley TJ, Slorach C, Reynolds JA, Hasni S, Thompson B, Ng L, Levy D, Silverman E, Kaplan MJ.
    Endothelial progenitor cell phenotype and function are impaired in childhood-onset systemic lupus erythematosus
    Arthritis Rheumatol. 2015 Apr 17. doi: 10.1002/art.39149. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25891295
  • Fassbinder T, Saunders U, Mickholz E, Jung E, Becker H, Schlüter B, Jacobi AM.
    Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus
    Arthritis Res Ther. 2015 Apr 3;17(1):92. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25890338
  • Bonanni A, Vaglio A, Bruschi M, Sinico RA, Cavagna L, Moroni G, Franceschini F, Allegri L, Pratesi F, Migliorini P, Candiano G, Pesce G, Ravelli A, Puppo F, Martini A, Tincani A, Ghiggeri GM.
    Multi-antibody composition in lupus nephritis: Isotype and antigen specificity make the difference
    Autoimmun Rev. 2015 Apr 14. pii: S1568-9972(15)00086-5. doi:
    0.1016/j.autrev.2015.04.004. [Epub ahead of print] 
    http://www.ncbi.nlm.nih.gov/pubmed/25888464 
  • Dall'Era M, Cisternas MG, Smilek DE, Straub L, Houssiau FA, Cervera R, Rovin BH, Mackay M.
    Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the euro-lupus nephritis cohort
    Arthritis Rheumatol. 2015 May;67(5):1305-13. doi: 10.1002/art.39026.
    http://www.ncbi.nlm.nih.gov/pubmed/25605554
  • Brunner HI1, Silva CA, Reiff A, Higgins GC, Imundo L, Williams CB, Wallace CA, Aikawa NE, Nelson S, Klein-Gitelman MS, Rose SR.
    Randomized, double-blind, dose-escalation trial of triptorelin for ovary protection in childhood-onset systemic lupus erythematosus
    Arthritis Rheumatol. 2015 May;67(5):1377-85. doi: 10.1002/art.39024.
    http://www.ncbi.nlm.nih.gov/pubmed/25676588

MARZO 2015
  • Steiman AJ, UrowitzMB, Ibañez D, Li TT, Gladman DD, Wither J.
    Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.
    J Rheumatol. 2015 Mar 1. pii: jrheum.140796. [Epub ahead of print].
    http://www.ncbi.nlm.nih.gov/pubmed/25729033
  • Ding JY, Ibañez D, Gladman DD, Urowitz MB.
    Isolated hematuria and sterile pyuria may indicate systemic lupus erythematosus activity.
    J Rheumatol. 2015 Mar;42(3):437-40. doi: 10.3899/jrheum.140415.
    http://www.ncbi.nlm.nih.gov/pubmed/25593226
  • Olfat M, Silverman ED, Levy DM.
    Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.
    Lupus. 2015 Mar 24. pii: 0961203315578764. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25804672
  • Doria A, Gatto M, Iaccarino L, Punzi L
    Value and goals of treat-to-target in systemic lupus erythematosus: knowledge and foresight.
    Lupus. 2015 Apr;24(4-5):507-15. doi: 10.1177/0961203314559087
    http://www.ncbi.nlm.nih.gov/pubmed/25801894
  • Watson P, Brennan A, Birch H, Fang H, Petri M.
    An integrated extrapolation of long-term outcomes in systemic lupus erythematosus: analysis and simulation of the Hopkins Lupus Cohort
    Rheumatology (2015) 54 (4): 623-632. doi:10.1093/rheumatology/keu375
    http://rheumatology.oxfordjournals.org/content/54/4/623.abstract
  • Castrejon I, Carmona L, Agrinier N, Andres M, Briot K, Caron M, Christensen R, Consolaro A, Curbelo R, Ferrer M, Foltz V, Gonzalez C, Guillemin F, Machado PM, Prodinger B, Ravelli A, Scholte-Voshaar M, Uhlig T, van Tuyl LH, Zink A, Gossec L.
    The EULAR Outcome Measures Library: development and an example from a systematic review for systemic lupus erythematous instruments
    Clin Exp Rheumatol. 2015 Mar 23. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25797345
  • Roldan CA, Tolstrup K, Macias L, Qualls CR, Maynard D, Charlton G, Sibbitt WL Jr.
    Libman-Sacks Endocarditis: Detection, Characterization, and Clinical Correlates by Three-Dimensional Transesophageal Echocardiography
    J Am Soc Echocardiogr. 2015 Mar 22. pii: S0894-7317(15)00130-3
    http://www.ncbi.nlm.nih.gov/pubmed/25807885
  • Merayo-Chalico J, Apodaca E, Barrera-Vargas A, Alcocer-Varela J, Colunga-Pedraza I, González-Patiño A, Arauz A, Abud-Mendoza C, Martínez-Martínez M, Gómez-Martín D.
    Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case-control study.
    J Neurol Neurosurg Psychiatry. 2015 Mar 24. pii: jnnp-2014-310145. doi: 10.1136/jnnp-2014-310145. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25804426
  • Bassi N, Del Prete D, Ghirardello A, Gatto M, Ceol M, Zen M, Bettio S, Mantovani A, Iaccarino L, Punzi L, Doria A.
    PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus Glomerulonephritis
    Clin Rev Allergy Immunol. 2015 Mar 25. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25805362
  • Kikuchi-Taura A, Yura A, Tsuji S, Ohshima S, Kitatoube A, Shimizu T, Nii T, Katayama M, Teshigawara S, Yoshimura M, Kudo-Tanaka E, Harada Y, Matsushita M, Hashimoto J, Saeki Y.
    Monocyte CD64 expression as a novel biomarker for the disease activity ofsystemic lupus erythematosus
    Lupus. 2015 Mar 24. pii: 0961203315579093. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25804673

FEBRERO 2015
  • Mrabet S, Benrhouma H, Kraoua I, Naas A, Achour NB, Klaa H, Turki I.
    Mixed movements disorders as an initial feature of pediatric lupus.
    Brain Dev. 2015 Feb 28.
    http://www.ncbi.nlm.nih.gov/pubmed/25736974
  • Singh S, Abujam B, Gupta A, Suri D, Rawat A, Saikia B, Walker Minz R, Joshi K, Nada R.
    Childhood lupus nephritis in a developing country-24 years' single-center experience from North India.
    Lupus. 2015 Feb 22.
    http://www.ncbi.nlm.nih.gov/pubmed/25712249
  • Vega-Fernandez P, Vanderburgh White S, Zelko F, Ruth NM, Levy DM, Muscal E, Klein-Gitelman MS, Huber AM, Tucker LB, Roebuck-Spencer T, Ying J, Brunner HI.
    Cognitive performance scores for the pediatric automated neuropsychological assessment metrics in childhood-onset systemic lupus erythematosus.
    Arthritis Care Res (Hoboken). 2015 Feb 23.
    http://www.ncbi.nlm.nih.gov/pubmed/25708844
  • Fotis L, Baszis KW, French AR, Cooper MA, White AJ.
    Mesenteric vasculitis in children with systemic lupus erythematosus.
    Clin Rheumatol. 2015 Feb 17.
    http://www.ncbi.nlm.nih.gov/pubmed/25687984
  • Sule SD, Moodalbail DG, Burnham J, Fivush B, Furth SL.
    Predictors of kidney disease in a cohort of pediatric patients with lupus.
    Lupus. 2015 Feb 12.
    http://www.ncbi.nlm.nih.gov/pubmed/25680740
  • Tambralli A, Beukelman T, Cron RQ, Stoll ML.
    Safety and Efficacy of Rituximab in Childhood-onset Systemic Lupus Erythematosus and Other Rheumatic Diseases.
    J Rheumatol. 2015 Mar;42(3):541-6.
    http://www.ncbi.nlm.nih.gov/pubmed/25593242

ENERO 2015
  • Fonseca AR, Gaspar-Elsas MI, Land MG, de Oliveira SK.
    Comparison between three systems of classification criteria in juvenile systemic lupus erythematous.
    Rheumatology (Oxford). 2015 Feb;54(2):241-7. doi: 10.1093/rheumatology/keu278. Epub 2014 Aug 14.
    http://www.ncbi.nlm.nih.gov/pubmed/25125590 
  • Tambralli A, Beukelman T, Cron RQ, Stoll ML.
    Safety and Efficacy of Rituximab in Childhood-onset Systemic Lupus Erythematosus and Other Rheumatic Diseases.
    J Rheumatol. 2015 Jan 15. pii: jrheum.140863. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25593242 
  • Watson L, Beresford MW, Maynes C, Pilkington C, Marks SD, Glackin Y, Tullus K.
    The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE.
    Lupus. 2015 Jan;24(1):10-7. doi: 10.1177/0961203314547793. Epub 2014 Aug 12.
    http://www.ncbi.nlm.nih.gov/pubmed/25117653 
  • Mina R, Klein-Gitelman MS, Nelson S, Eberhard BA, Higgins G, Singer NG, Onel K, Tucker L, O'Neil KM, Punaro M, Levy DM, Haines K, Ying J, Brunner HI.
    Effects of obesity on health-related quality of life in juvenile-onset systemic lupus erythematosus.
    Lupus. 2015 Feb;24(2):191-7. doi: 10.1177/0961203314555537. Epub 2014 Oct 21.
    http://www.ncbi.nlm.nih.gov/pubmed/25335488 
  • Rozenblyum EV, Levy DM, Allen U, Harvey E, Hebert D, Silverman ED.
    Cytomegalovirus in pediatric systemic lupus erythematosus: prevalence and clinical manifestations.
    Lupus. 2015 Jan 6. pii: 0961203314565443. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25568145

DICIEMBRE 2014

  • Tarr T, Dérfalvi B, Győri N, Szántó A, Siminszky Z, Malik A, Szabó AJ, Szegedi G, Zeher M.
    Similarities and differences between pediatric and adult patients with systemic lupus erythematosus.
    Lupus. 2014 Dec 15. pii: 0961203314563817.
    http://www.ncbi.nlm.nih.gov/pubmed/25516474
  • Mahmoudi M1, Tahghighi F, Ziaee V, Harsini S, Rezaei A, Soltani S, Sadr M, Moradinejad MH, Aghighi Y, Rezaei N.
    Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus.
    Int J Immunogenet. 2014 Dec;41(6):512-7.
    http://www.ncbi.nlm.nih.gov/pubmed/25320043
  • Wei CC, Lin CL, Tsai JD, Shen TC, Sung FC.
    Increased Incidence of juvenile onset systemic lupus erythematosus in children with atopic dermatitis.
    Lupus. 2014 Dec;23(14):1494-9.
    http://www.ncbi.nlm.nih.gov/pubmed/25057040
  • Levy DM, Peschken CA, Tucker LB, Chédeville G, Huber AM, Pope JE; Canadian Network for Improved Outcomes in SLE (CaNIOS) 1000 Faces Investigators, Silverman ED.
    Association of health-related quality of life in childhood-onset systemic lupus erythematosus with ethnicity: results from a multiethnic multicenter canadian cohort.
    Arthritis Care Res (Hoboken). 2014 Dec;66(12):1767-74.
    http://www.ncbi.nlm.nih.gov/pubmed/24821613
  • Leal GN, Silva KF, França CM, Lianza AC, Andrade JL, Campos LM, Bonfá E, Silva CA.
    Subclinical right ventricle systolic dysfunction in childhood-onset systemic lupus erythematosus: insights from two-dimensional speckle-tracking echocardiography.
    Lupus. 2014 Dec 8. pii: 0961203314563135. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25492941

NOVIEMBRE 2014
 
Lups Eritematoso Juvenil
    • Stagi S, Cavalli L, Bertini F, Signorini C, Matucci Cerinic M, de Martino M, Brandi ML, Falcini F. Comparison of bone mass and quality determinants in adolescents and young adults with juvenile systemic lupus erythematosus (JSLE) and juvenile idiopathic arthritis (JIA).
      Lupus. 2014 Nov;23(13):1392-406.
      http://www.ncbi.nlm.nih.gov/pubmed/?term=25074873
    • Wei CC, Lin CL, Tsai JD, Shen TC, Sung FC.
      Increased Incidence of juvenile onset systemic lupus erythematosus in children with atopic dermatitis.
      Lupus. 2014 Dec;23(14):1494-9.
      http://www.ncbi.nlm.nih.gov/pubmed/?term=25057040 
    • Levy DM, Peschken CA, Tucker LB, Chédeville G, Huber AM, Pope JE; Canadian Network for Improved Outcomes in SLE (CaNIOS) 1000 Faces Investigators, Silverman ED.
      Association of health-related quality of life in childhood-onset systemic lupus erythematosus with ethnicity: results from a multiethnic multicenter canadian cohort.
      Arthritis Care Res (Hoboken). 2014 Dec;66(12):1767-74.
      http://www.ncbi.nlm.nih.gov/pubmed/?term=24821613
    • Mahmoudi M, Tahghighi F, Ziaee V, Harsini S, Rezaei A, Soltani S, Sadr M, Moradinejad MH, Aghighi Y, Rezaei N.
      Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus.
      Int J Immunogenet. 2014 Dec;41(6):512-7.
      http://www.ncbi.nlm.nih.gov/pubmed/?term=25320043

Neonatal Lupus

OCTUBRE 2014
  • Chiewchengchol D, Midgley A, Sodsai P, Deekajorndech T, Hirankarn N, Beresford MW, Edwards SW.
    The protective effect of GM-CSF on serum-induced neutrophil apoptosis in juvenile systemic lupus erythematosus patients.
    Clin Rheumatol. 2014 Oct 26. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25344776 
  • Mina R, Klein-Gitelman MS, Nelson S, Eberhard BA, Higgins G, Singer NG, Onel K, Tucker L, O'Neil KM, Punaro M, Levy DM, Haines K, Ying J, Brunner HI.
    Effects of obesity on health-related quality of life in juvenile-onset systemic lupus erythematosus.
    Lupus. 2014 Oct 21. pii: 0961203314555537. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25335488 
  • Al Hamzi H1, Alhaymouni B, Al Shaikh A,Al-Mayouf SM.
    Outcome of adult Saudi patients with childhood-onset systemic lupus erythematosus.
    Clin Exp Rheumatol. 2014 Aug 15. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25152255 
  • Alhanouf AlSaleem, Ashwaq AlE’ed, Afaf AlSaghier, Sulaiman M. Al-Mayouf
    Vitamin D status in children with systemic lupus erythematosus and its association with clinical and laboratory parameters
    Clinical Rheumatology  Nov 2014. DOI 10.1007/s10067-014-2811-z                   
    http://link.springer.com/article/10.1007/s10067-014-2811-z
  • F E Mackie,G Kainer, N Adib, C Boros, E J Elliott, R Fahy, et al.
    The national incidence and clinical picture of SLE in children in Australia – a report from the Australian Paediatric Surveillance Unit.
    Lupus. Published online before print October 6, 2014, doi: 10.1177/0961203314552118
    http://m.lup.sagepub.com/content/early/2014/10/06/0961203314552118
  • H-T Chung, Y-L Huang, K-W Yeh, J-L Huang
    Subclinical deterioration of left ventricular function in patients with juvenile-onset systemic lupus erythematosusLupus. Published online before print October 9, 2014, doi: 10.1177/0961203314554249
    http://m.lup.sagepub.com/content/early/2014/10/09/0961203314554249

SEPTIEMBRE 2014
  • Knight A, Weiss P, Morales K, Gerdes M, Gutstein A, Vickery M, Keren R.
    Depression and anxiety and their association with healthcare utilization in pediatric lupus and mixed connective tissue disease patients: a cross-sectional study.
    Pediatr Rheumatol Online J. 2014 Sep 10;12:42. doi: 10.1186/1546-0096-12-42. eCollection 2014.
    http://www.ncbi.nlm.nih.gov/pubmed/25242900
  • Moroni G, Raffiotta F, Trezzi B, Giglio E, Mezzina N, Del Papa N, Meroni P, Messa P, Sinico AR.
    Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
    Rheumatology 2014 Sep;53 (9):1570-1577.
    http://rheumatology.oxfordjournals.org/content/53/9/1570.abstract
  • Zuniga Zambrano YC, Guevara Ramos JD, Penagos Vargas NE, Benitez Ramirez DC, Ramirez Rodriguez SM, Vargas Niño AC, Izquierdo Bello AH.
    Risk factors for neuropsychiatric manifestations in children with systemic lupus erythematosus: case-control study.
    Pediatr Neurol. 2014 Sep;51(3):403-9.
    http://www.ncbi.nlm.nih.gov/pubmed/25159157
  • Leffler J, Bengtsson AA, Blom AM.
    The complement system in systemic lupus erythematosus: an update.
    Ann Rheum Dis. 2014 Sep;73(9):1601-1606.
    http://www.ncbi.nlm.nih.gov/pubmed/24845390

 AGOSTO 2014
  • Kizawa T, Nozawa T, Kikuchi M, Nagahama K, Okudela K, Miyamae T, Imagawa T, Nakamura T, Mori M, Yokota S, Tsutsumi H.
    Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.
    Mod Rheumatol. 2014 Aug 27:1-5. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25159157
  • Fonseca AR, Gaspar-Elsas MI, Land MG, de Oliveira SK.
    Comparison between three systems of classification criteria in juvenile systemic lupus erythematous.
    Rheumatology (Oxford). 2014 Aug 14. pii: keu278. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25125590

JULIO 2014
  • Peracchi OA1, Terreri MT2, Munekata RV1, Len CA2, Sarni RO1, Lazaretti-Castro M3, Hilário MO1.
    Low serum concentrations of 25-hydroxyvitamin D in children and adolescents with systemic lupus erythematosus.
    Braz J Med Biol Res. 2014 Jul 18;0:0. 
    http://www.ncbi.nlm.nih.gov/pubmed/25055165
  • Wei CC1, Lin CL2, Tsai JD3, Shen TC4, Sung FC5.
    Increased Incidence of juvenile onset systemic lupus erythematosus in children with atopic dermatitis.
    Lupus. 2014 Jul 23. 
    http://www.ncbi.nlm.nih.gov/pubmed/25057040
  • Chan PC1, Yu CH2, Yeh KW1, Horng JT3, Huang JL4.
    Comorbidities of pediatric systemic lupus erythematosus: A 6-year nationwide population-based study.
    J Microbiol Immunol Infect. 2014 Jul 24. 
    http://www.ncbi.nlm.nih.gov/pubmed/25066707
  • Lourenço D1, Cunha Gomes R1, Aikawa N2, Campos L1, Romiti R3, Silva C4.
    Childhood-onset bullous systemic lupus erythematosus.
    Lupus. 2014 Jul 29. 
    http://www.ncbi.nlm.nih.gov/pubmed/25074872
  • Gad GI1, Abdelateef H.
    Function of the audiovestibular system in children with systemic lupus erythematosus.
    Curr Allergy Asthma Rep. 2014 Jul;14(7):446. doi: 10.1007/s11882-014-0446-4.

JUNIO 2014

MAYO 2014
  • Levy DM1, Peschken CA, Tucker LB, Chédeville G, Huber AM, Pope JE; Canadian Network for Improved Outcomes in SLE (CaNIOS) 1000 Faces Investigators,Silverman ED.
    Health related quality of life in childhood-onset systemic lupus erythematosus is associated with ethnicity: Results from a multiethnic multicenter canadian cohort.
    Arthritis Care Res (Hoboken). 2014 May 12. doi: 10.1002/acr.22363. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24821613
  • Pisoni CN1, Muñoz SA2, Carrizo C3, Cosatti M3, Alvarez A4, Dubinsky D5, Bresan E5, Russo R6, Borgia E6, García M7, Sansinanea P7, Basta MC2, D́amico MA8,Barreira JC8, Lancioni E9, Soriano E9, Cunto CD9, Beron A5, Eimon A3.
    Multicentric prevalence study of anti P ribosomal autoantibodies in juvenile onset systemic lupus erythematosuscompared with adult onset systemic lupus erythematosus.
    Reumatol Clin. 2014 May 7. pii: S1699-258X(14)00083-7. doi: 10.1016/j.reuma.2014.03.007. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24816340

ABRIL 2014
  • Boneparth A, Ilowite N; for the CARRA Registry Investigators.
    Comparison of renal response parameters for juvenile membranous plus proliferative lupus nephritis versus isolated proliferative lupus nephritis: a cross-sectional analysis of the CARRA Registry.
    Lupus. 2014 Apr 11. [Epub ahead of print]
  • Ale'ed A, Alsonbul A, Al-Mayouf SM
    Safety and efficacy of combined cyclophosphamide and rituximab treatment in recalcitrant childhood lupus.
    Rheumatol Int. 2014 Apr;34(4):529-33. doi: 10.1007/s00296-013-2896-8.
    http://www.ncbi.nlm.nih.gov/pubmed/24218286

MARZO 2014
  • Chiewchengchol D1, Murphy R, Morgan T, Edwards SW, Leone V, Friswell M, Pilkington C, Tullus K, Rangaraj S, McDonagh JE, Gardner-Medwin J, Wilkinson N, Riley P, Tizard J, Armon K, Sinha MD, Ioannou Y, Mann R, Bailey K, Davidson J, Baildam EM, Pain CE, Cleary G, McCann LJ, Beresford MW; on behalf of the UK JSLE Study Group.
    Mucocutaneousmanifestations in a UKnationalcohort of juvenile onsetsystemiclupuserythematosuspatients.
    Rheumatology (Oxford). 2014 Mar 31. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24692572
  • Smith EM, Foster HE, Gray WK, Taylor-Robinson D, Beresford MW; UK JSLE Study Group.
    Predictors of access to care in juvenile systemic lupus erythematosus: evidence from the UK JSLE Cohort Study.
    Rheumatology (Oxford). 2014 Mar;53(3):557-61. doi: 10.1093/rheumatology/ket402. Epub 2013 Dec 5.
    http://www.ncbi.nlm.nih.gov/pubmed/24310297
  • Watson L, Tullus K, Pilkington C, Chesters C, Marks SD, Newland P, Jones CA, Beresford MW.
    Urine biomarkers for monitoring juvenile lupus nephritis: a prospective longitudinal study.
    Pediatr Nephrol. 2014 Mar;29(3):397-405. doi: 10.1007/s00467-013-2668-4. Epub 2013 Nov 16.
    http://www.ncbi.nlm.nih.gov/pubmed/24241909
  • Knight AM, Weiss PF, Morales KH, Keren R.
    National trends in pediatric systemic lupus erythematosus hospitalization in the United States: 2000-2009.
    J Rheumatol. 2014 Mar;41(3):539-46. doi: 10.3899/jrheum.130592. Epub 2014 Feb 1.
    http://www.ncbi.nlm.nih.gov/pubmed/24488419

FEBERERO 2014
  • Midgley A, Watson L, Beresford MW.
    New insights into the pathogenesis and management of lupus in children.
    Arch Dis Child. 2014 Feb 28. doi: 10.1136/archdischild-2013-304397. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24585754
  • Rozenblyum EV, Allen UD, Silverman ED, Levy DM.
    Cytomegalovirus infection in childhood-onset systemic lupus erythematosus.
    Int J Clin Rheumtol. 2013 Feb;8(1):137-146.
    http://www.ncbi.nlm.nih.gov/pubmed/24527062
  • Toulany A, Katzman DK, Kaufman M, Hiraki LT, Silverman ED.
    Chicken or the egg: anorexia nervosa and systemic lupus erythematosus in children and adolescents.
    Pediatrics. 2014 Feb;133(2):e447-50. doi: 10.1542/peds.2012-3048. Epub 2014 Jan 6.
    http://www.ncbi.nlm.nih.gov/pubmed/24394681
  • Yavuz S, Ece A.
    Mean platelet volume as an indicator of disease activity in juvenile SLE.
    Clin Rheumatol. 2014 Feb 25. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24567240
  • Somers EC, Marder W, Cagnoli P, Lewis EE, Deguire P, Gordon C, Helmick CG, Wang L, Wing JJ, Dhar JP, Leisen J, Shaltis D, McCune WJ.
    Population-based incidence and prevalence of systemic lupus erythematosus: the michigan lupus epidemiology and surveillance program.
    Arthritis Rheumatol. 2014 Feb;66(2):369-78. doi: 10.1002/art.38238.
    http://www.ncbi.nlm.nih.gov/pubmed/24504809
    http://onlinelibrary.wiley.com/doi/10.1002/art.38238/pdf
  • Knight AM, Weiss PF, Morales KH, Keren R.
    National Trends in Pediatric Systemic Lupus Erythematosus Hospitalization in the United States: 2000-2009.
    J Rheumatol. 2014 Feb 1. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24488419
  • Lim SS, Bayakly AR, Helmick CG, Gordon C, Easley KA, Drenkard C.
    The incidence and prevalence of systemic lupus erythematosus, 2002-2004: the georgia lupus registry.
    Arthritis Rheumatol. 2014 Feb;66(2):357-68. doi: 10.1002/art.38239.
    http://www.ncbi.nlm.nih.gov/pubmed/24504808
    http://onlinelibrary.wiley.com/doi/10.1002/art.38239/pdf
  • Amaral B, Murphy G, Ioannou Y, Isenberg DA.
    A comparison of the outcome of adolescent and adult-onset systemic lupus erythematosus.
    Rheumatology (Oxford). 2014 Feb 6. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24505121
  • Moroni G, Raffiotta F, Trezzi B, Giglio E, Mezzina N, Del Papa N, Meroni P, Messa P, Sinico AR.
    Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study
    Rheumatology (Oxford). 2014 Feb 6. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24505125
  • Furie R, Nicholls K, Cheng TT, Houssiau F, Burgos-Vargas R, Chen SL, Hillson JL, Meadows-Shropshire S, Kinaszczuk M, Merrill JT.
    Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study.
    Arthritis Rheumatol. 2014 Feb;66(2):379-89. doi: 10.1002/art.38260.
    http://www.ncbi.nlm.nih.gov/pubmed/24504810
    http://onlinelibrary.wiley.com/doi/10.1002/art.38260/pdf
  • Mina R, Klein-Gitelman MS, Nelson S, Eberhard BA, Higgins G, Singer NG, Onel K, Tucker L, O'Neil KM, Punaro M, Levy DM, Haines K, Martini A, Ruperto N, Lovell DJ, Brunner HI.
    Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus
    Ann Rheum Dis 2014;73:401-406 doi:10.1136/annrheumdis-2012-202376
    http://ard.bmj.com/content/73/2/401.abstract
  • Ginzler EM, Wallace DJ, Merrill JT, Furie RA, Stohl W, Chatham WW, Weinstein A, McKay JD, McCune WJ, Zhong ZJ, Freimuth WW, Petri MA; LBSL02/99 Study Group.
    Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus.
    J Rheumatol. 2014 Feb;41(2):300-9. doi: 10.3899/jrheum.121368. Epub 2013 Nov 1.
    http://www.ncbi.nlm.nih.gov/pubmed/24187095

ENERO 2014
  • Lehman TJ, Singh C, Ramanathan A, Alperin R, Adams A, Barinstein L, Moorthy N
    Prolonged improvement of childhood onset systemic lupus erythematosus following systematic administration of rituximab and cyclophosphamide
    Pediatr Rheumatol Online J. 2014 Jan 14;12(1):3. doi: 10.1186/1546-0096-12-3.
  • Son MB, Johnson VM, Hersh AO, Lo MS, Costenbader KH.
    Outcomes in hospitalized pediatric patients with systemic lupus erythematosus.
    Pediatrics. 2014 Jan;133(1):e106-13. doi: 10.1542/peds.2013-1640. Epub 2013 Dec 30.
    http://www.ncbi.nlm.nih.gov/pubmed/24379234

DICIEMBRE 2013
  • Stagi S, Cavalli L, Bertini F, Cerinic MM, Brandi ML, Falcini F.
    Cross-sectional and longitudinal evaluation of bone mass and quality in children and young adults with juvenile onset systemic lupus erythematosus (JSLE): role of bone mass determinants analyzed by DXA, PQCT and QUS.
    Lupus. 2014;23(1):57-68. doi: 10.1177/0961203313511679. Epub 2013 Nov 11.
    http://www.ncbi.nlm.nih.gov/pubmed/24218395

OCTUBRE 2013

SEPTIEMBRE 2013

JULIO 2013
  • Campos LM, Silva CA, Aikawa NE, Jesus AA, Moraes JC, Miraglia J, Ishida MA, Bueno C, Pereira RM, Bonfa E.
    High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.
    Arthritis Care Res (Hoboken). 2013 Jul;65(7):1121-7. doi: 10.1002/acr.21948.
    http://www.ncbi.nlm.nih.gov/pubmed/23818263

MAYO 2013
  • Gladman DD, Ibañez D, Ruiz I, Urowitz MB
    Recommendations for frequency of visits to monitor systemic lupus erythematosus in asymptomatic patients: data from an observational cohort study.
    J Rheumatol 2013 May;40(5):630-3. doi: 10.3899/jrheum.121094.
    http://www.ncbi.nlm.nih.gov/pubmed/23457385
  • Rianthavorn P, Chokedeemeeboon C, Deekajorndech T, Suphapeetiporn K.
    Interleukin-10 promoter polymorphisms and expression in Thai children with juvenile systemic lupus erythematosus.
    Lupus 2013 May 2. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/23640982
  • Kohut SA, Williams T, Jayanthikumar J, Landolt-Marticorena C, Lefebvre A, Silverman E, Levy D.
    Depressive symptoms are prevalent in childhood-onset systemic lupus erythematosus (cSLE).
    Lupus. 2013 May 23. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/23704369
  • Kohut SA, Williams T, Jayanthikumar J, Landolt-Marticorena C, Lefebvre A, Silverman E, Levy D. Gitelman DR, Klein-Gitelman MS, Ying J, Sagcal-Gironella AC, Zelko F, Beebe DW, Difrancesco M, Parrish T, Hummel J, Beckwith T, Brunner HI.
    Brain morphometric changes associated with childhood-onset systemic lupus erythematosus and neurocognitive deficit.
    Arthritis Rheum 2013 May 10. doi: 10.1002/art.38009. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/23666759
  • Ingegnoli F.
    Capillaroscopy abnormalities in relation to disease activity in juvenile systemic lupus erythematosus.
    Microvasc Res 2013 May;87:92-4. doi: 10.1016/j.mvr.2013.02.004. Epub 2013 Feb 26.
    http://www.ncbi.nlm.nih.gov/pubmed/23485586
  • Mok CC, Ho LY, Fong LS, To CH.
    Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study.
    Ann Rheum Dis 2013; 72:659-64. doi: 10.1136/annrheumdis-2012-201393
    http://www.ncbi.nlm.nih.gov/pubmed/22589375
  • Jónsdóttir T, Zickert A, Sundelin B, Henriksson EW, van Vollenhoven RF, Gunnarsson I.
    Long-term follow-up in lupus nephritis patients treated with rituximab—clinical and histopathological response
    Rheumatology 2013 May; 52:847-55 doi:10.1093/rheumatology/kes348.
    http://rheumatology.oxfordjournals.org/content/52/5/847.abstract

MARZO 2013
  • Sozeri B, Deveci M, Dincel N, Mir S. Pediatr Nephrol.
    The early cardiovascular changes in pediatric patients with systemic lupus erythematosus. 
    Pediatr Nephrol. 2013 Mar;28(3):471-6. doi: 10.1007/s00467-012-2342-2. Epub 2012 Nov 8.
    http://www.ncbi.nlm.nih.gov/pubmed/23135607
  • Brunner HI, Klein-Gitelman MS, Zelko F, Thomas EC, Hummel J, Nelson SM, Huggins J, Curran ML, Roebuck-Spencer T, Beebe DW, Ying J.
    Validation of the Pediatric Automated Neuropsychological Assessment Metrics in childhood-onset systemic lupuserythematosus.
    Arthritis Care Res (Hoboken). 2013 Mar;65(3):372-81. doi: 10.1002/acr.21835.
    http://onlinelibrary.wiley.com/doi/10.1002/acr.21835/pdf

ENERO 2013
  • Mina R, Klein-Gitelman MS, Nelson S, Eberhard BA, Higgins G, Singer NG, Onel K, Tucker L, O'Neil KM, Punaro M, Levy DM, Haines K,Martini A, Ruperto N, Lovell D, Brunner HI.
    Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus.
    Ann Rheum Dis. 2013 Jan 23. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/23345596
  • Levy DM, Peschken CA, Tucker LB, Chédeville G, Huber AM, Pope JE and the Canadian Network for Improved Outcomes in SLE 1000 Faces Investigators and Silverman ED.
    Influence of ethnicity on childhood-onset systemic lupus erythematosus: Results from a multiethnic multicenter Canadian cohort.
    Arthritis Care Res 2013 Jan; 65 (1):152-60. DOI: 10.1002/acr.21779.
    http://onlinelibrary.wiley.com/doi/10.1002/acr.21779/abstract

DICIEMBRE 2012
  • Livingston B, Bonner A, Pope J
    Differences in autoantibody profiles and disease activity and damage scores between childhood- and adult-onset systemic lupus erythematosus: a meta-analysis.
    Semin Arthritis Rheum. 2012 Dec;42(3):271-80. doi: 10.1016/j.semarthrit.2012.05.001.
    http://www.ncbi.nlm.nih.gov/pubmed/22704358

NOVIEMBRE 2012
  • Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, Boletis J, Cervera R, Dörner T, Doria A, Ferrario F, Floege J, Houssiau FA, Ioannidis JP, Isenberg DA, Kallenberg CG, Lightstone L, Marks SD, Martini A, Moroni G, Neumann I, Praga M, Schneider M, Starra A, Tesar V, Vasconcelos C, van Vollenhoven RF, Zakharova H, Haubitz M, Gordon C, Jayne D, Boumpas DT.
    Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.
    Ann Rheum Dis. 2012 Nov;71(11):1771-82. doi: 10.1136/annrheumdis-2012-201940. Epub 2012 Jul 31.

AGOSTO 2012
  • Hiraki LT, Feldman CH, Liu J, Alarcón GS, Fischer MA, Winkelmayer WC, Costenbader KH.
    Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population.
    Arthritis Rheum 2012 Aug;64(8):2669-76. doi: 10.1002/art.34472.
    http://www.ncbi.nlm.nih.gov/pubmed/22847366

JULIO 2012
  • Watson L, Leone V, Pilkington C, Tullus K, Rangaraj S, McDonagh JE, Gardner-Medwin J, Wilkinson N, Riley P, Tizard J, Armon K, Sinha MD, Ioannou Y, Archer N, Bailey K, Davidson J, Baildam EM, Cleary G, McCann LJ, Beresford MW; UK Juvenile-Onset Systemic Lupus Erythematosus Study Group.
    Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort.
    Arthritis Rheum. 2012 Jul;64(7):2356-65. doi: 10.1002/art.34410.
PATROCINADORES

Área de Socios